No evidence of an increase of bacterial and viral infections following measles, mumps and rubella vaccine
Abstract
The suggestion that multi-antigen vaccines might overload the immune system has led to calls for single antigen vaccines. In 2003 we showed that rather than an increase there appeared to be a reduced risk of severe bacterial infection in the three months following Measles, Mumps and Rubella vaccine (MMR). The present analysis of illnesses in a general population is based on an additional 10 years of data for bacterial infections and also includes admissions with viral infections. Analyses were carried out using the self-controlled case-series method and separately for bacterial and viral infection cases, using risk periods of 0-30 days, 31-60 days and 61-90 days post MMR vaccine. An analysis was also carried out for those cases which were given MMR and Meningococcal serogroup C (MCC) vaccines concomitantly. A reduced risk was seen in the 0-30-day period for both bacterial infection (relative incidence=0.68, 95% CI 0.54-0.86) and viral infections (relative incidence=0.68, 95% CI 0.49-0.93). There was no increased risk in any period when looking at combined viral or bacterial infections or for individual infections with the single exception of an increased risk in the 31-60 days post vaccination period for herpes infections (relative incidence=1.69, 95% CI 1.06-2.70). For the children given Meningococcal group C vaccines concomitantly no significantly increased risk was seen in either the bacterial (relative incidence=0.54, 95% CI 0.26-1.13) or viral cases (relative incidence=0.46, 95% CI 0.11-1.93). Our study confirms that the MMR vaccine does not increase the risk of invasive bacterial or viral infection in the 90 days after the vaccination and does not support the hypothesis that there is an induced immune deficiency due to overload from multi-antigen vaccines.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
No significant differences were found comparing incidence of invasive bacterial diseases in risk periods with that of background period.
“No significant differences were found comparing incidence of invasive bacterial diseases in risk periods with that of background period.”
From Vaccines for measles, mumps and rubella in children (2012) · cites this paper as Stowe 2009
Admissions for lobar pneumonia were less frequent in the time between 0 and 30 days after MMR immunisation (RI 0.65; 95% CI 0.48 to 0.86) or during the 90 days following immunisation (RI 0.77; 95% CI 0.64 to 0.93).
“Admissions for lobar pneumonia were less frequent in the time between 0 and 30 days after MMR immunisation (RI 0.65; 95% CI 0.48 to 0.86) or during the 90 days following immunisation (RI 0.77; 95% CI 0.64 to 0.93).”
From Vaccines for measles, mumps and rubella in children (2012) · cites this paper as Stowe 2009
In a self-controlled case series, increased risk of herpes was found between 31 and 60 days after MMR immunisation (OR 1.69; 95% CI 1.06 to 2.70), with no significant association for other time intervals.
“Increased risk between 31 and 60 days after immunisation (OR 1.69; 95% CI from 1. 06 to 2.70) .No significant association for the other time intervals”
From Vaccines for measles, mumps and rubella in children (2012) · cites this paper as Stowe 2009
Multiple studies have shown that children who received vaccinations had a similar, or even reduced, risk of unconnected infections in the following period.
“multiple studies have shown that children who received vaccinations had a similar, or even reduced, risk of unconnected infections in the following period92–95.”
From A guide to vaccinology: from basic principles to new developments (2021) · cites this paper as [92]
Cites
1 retracted
Wakefield, A., Murch, S., Anthony, A., Linnell, J., Casson, D., Malik, M., Berelowitz, M., Dhillon, A., Thomson, M., Harvey, P., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11096-0 · Cited by 3,006 · see citing works
RetractedAddressing parents’ concerns: do multiple vaccines overwhelm or weaken the infant's immune system?
Offit, P. A., Quarles, J., Gerber, M. A., Hackett, C. J., Marcuse, E. K., Kollman, T. R., Gellin, B. G., & Landry, S. (2002) · Pediatrics · doi:10.1542/peds.109.1.124 · Cited by 312 · see citing works
<i>CISH</i> and Susceptibility to Infectious Diseases
Khor, C. C., Vannberg, F. O., Chapman, S. J., Guo, H., Wong, S. H., Walley, A. J., Vukcevic, D., Rautanen, A., Mills, T. C., Chang, K.-C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905606 · Cited by 136 · see citing works
Circulating Interferon after Measles Vaccination
Petralli, J. K., Merigan, T. C., & Wilbur, J. R. (1965) · New England Journal of Medicine · doi:10.1056/nejm196507222730405 · Cited by 99 · see citing works
Measles, mumps, rubella vaccine: through a glass, darkly.
Wakefield, A. J., & Montgomery, S. (2000) · PubMed · Cited by 82 · see citing works
Okada, H., Sato, T. A., Katayama, A., Higuchi, K., Shichijo, K., Tsuchiya, T., Takayama, N., Takeuchi, Y., Abe, T., Okabe, N., et al. (2001) · Archives of Virology · doi:10.1007/s007050170121 · Cited by 66 · see citing works
Objective Structured Clinical Examination in a Pediatric Residency Program
Joorabchi, B. (1991) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1991.02160070053021 · Cited by 65 · see citing works
Statistical assessment of the association between vaccination and rare adverse events post-licensure
Andrews, N. J. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00280-8 · Cited by 50 · see citing works
Bacterial infections, immune overload, and MMR vaccine
Miller, E. J. (2003) · Archives of Disease in Childhood · doi:10.1136/adc.88.3.222 · Cited by 41 · see citing works
Institute of Medicine (2002) · National Academies Press eBooks · doi:10.17226/10306 · Cited by 37 · see citing works
Apparent Decreased Risk of Invasive Bacterial Disease After Heterologous Childhood Immunization
BLACK, S. B. (1991) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1991.02160070042019 · Cited by 32 · see citing works
Childhood vaccination and nontargeted infectious disease hospitalization.
Hviid, A. (2005) · JAMA · doi:10.1001/jama.294.6.699 · Cited by 31 · see citing works
Immunization Safety Review: Multiple Immunizations and Immune Dysfunction
Prevention, D. (2020) · Cited by 29 · see citing works
Otto, S., Mahner, B., Kadow, I., Beck, J. F., Wiersbitzky, S. K. W., & Bruns, R. (2000) · Journal of Infection · doi:10.1053/jinf.2000.0718 · Cited by 27 · see citing works
DTP immunization and susceptibility to infectious diseases. Is there a relationship?
Davidson, M., Letson, G. W., Ward, J. I., Ball, A., BULKOW, L. R., Christenson, P. D., & Cherry, J. D. (1991) · PubMed · Cited by 21 · see citing works
Griffin, M. R., Taylor, J. A., Daugherty, J. R., & Ray, W. A. (1992) · Pediatrics · doi:10.1542/peds.89.4.640 · Cited by 17 · see citing works
Feasibility study for identifying adverse events attributable to vaccination by record linkage
Nash, J. Q., Chandrakumar, M., Farrington, P., Williamson, S., & Miller, E. (1995) · Epidemiology and Infection · doi:10.1017/s0950268800052183 · Cited by 16 · see citing works
Does recent vaccination increase the risk of occult bacteremia?
Burstein, J. L., & FLEISHER, G. R. (1994) · Pediatric Emergency Care · doi:10.1097/00006565-199406000-00004 · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
A guide to vaccinology: from basic principles to new developments
Pollard, A. J., & Bijker, E. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00479-7 · Cited by 1,593 · see citing works
Self controlled case series methods: an alternative to standard epidemiological study designs
Petersen, I., Douglas, I., & Whitaker, H. (2016) · BMJ · doi:10.1136/bmj.i4515 · Cited by 525 · see citing works
Vaccines for measles, mumps and rubella in children
Demicheli, V., Rivetti, A., Debalini, M. G., & Di Pietrantonj, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004407.pub3 · Cited by 372 · see citing works
Vaccines for measles, mumps, rubella, and varicella in children
Pietrantonj, C. D., Rivetti, A., Marchione, P., Debalini, M. G., & Demicheli, V. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004407.pub4 · Cited by 197 · see citing works
How to Communicate With Vaccine-Hesitant Parents
Healy, C. M., & Pickering, L. K. (2011) · PEDIATRICS · doi:10.1542/peds.2010-1722s · Cited by 182 · see citing works
Sørup, S., Benn, C. S., Poulsen, A., Krause, T. G., Aaby, P., & Ravn, H. (2014) · JAMA · doi:10.1001/jama.2014.470 · Cited by 181 · see citing works
Meningococcal C conjugate vaccine: the experience in England and Wales
Campbell, H., Borrow, R., Salisbury, D., & Miller, E. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.067 · Cited by 168 · see citing works
Ghebremichael‐Weldeselassie, Y., Whitaker, H., & Farrington, P. (2011) · Epidemiology and Infection · doi:10.1017/s0950268811001531 · Cited by 128 · see citing works
Li, X., Raventós, B., Roel, E., Pistillo, A., Martinez-Hernandez, E., Delmestri, A., Reyes, C., Strauss, V., Prieto-Alhambra, D., Burn, E., et al. (2022) · BMJ · doi:10.1136/bmj-2021-068373 · Cited by 118 · see citing works
Nonspecific Effects of Vaccines
Goldblatt, D., & Miller, E. (2014) · JAMA · doi:10.1001/jama.2014.471 · Cited by 101 · see citing works
Vaccines for measles, mumps, rubella, and varicella in children
Pietrantonj, C. D., Rivetti, A., Marchione, P., Debalini, M. G., & Demicheli, V. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004407.pub5 · Cited by 100 · see citing works
Accelerating Control of Pertussis in England and Wales
Campbell, H. J., Amirthalingam, G., Andrews, N. J., Fry, N. K., George, R. C., Harrison, T. G., & Miller, E. (2012) · Emerging infectious diseases · doi:10.3201/eid1801.110784 · Cited by 90 · see citing works
Siegrist, C. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00004-5 · Cited by 86 · see citing works
Siegrist, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00002-x · Cited by 75 · see citing works
COVID-19 vaccine platforms: Delivering on a promise?
Verdecia, M. A., Kokai‐Kun, J. F., Kibbey, M., Acharya, S., Venema, J., & Atouf, F. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1911204 · Cited by 55 · see citing works
Vaccines for measles, mumps and rubella in children
Demicheli, V., Rivetti, A., Debalini, M. G., & Pietrantonj, C. D. (2013) · Evidence-Based Child Health A Cochrane Review Journal · doi:10.1002/ebch.1948 · Cited by 51 · see citing works
Biological considerations of plasma-derived and recombinant factor VIII immunogenicity
Lai, J. D., Hough, C. A., Tarrant, J., & Lillicrap, D. (2017) · Blood · doi:10.1182/blood-2016-11-750885 · Cited by 48 · see citing works
Measles–mumps–rubella vaccination and respiratory syncytial virus-associated hospital contact
Sørup, S., Benn, C. S., Stensballe, L. G., Aaby, P., & Ravn, H. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.07.110 · Cited by 35 · see citing works
Immune overload: Parental attitudes toward combination and single antigen vaccines
Hulsey, E., & Bland, T. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.04.020 · Cited by 32 · see citing works
Concurrent influenza vaccination reduces anti-FVIII antibody responses in murine hemophilia A
Lai, J. D., Moorehead, P. C., Sponagle, K., Steinitz, K. N., Reipert, B. M., Hough, C. A., & Lillicrap, D. (2016) · Blood · doi:10.1182/blood-2015-11-679282 · Cited by 30 · see citing works
Miller, E., Andrews, N. J., Waight, P., Findlow, H., Ashton, L., England, A., Stanford, E., Matheson, M., Southern, J., Sheasby, E., et al. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00516-10 · Cited by 28 · see citing works
Stowe, J., Andrews, N. J., Bryan, P. T., Seabroke, S., & Miller, E. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.10.029 · Cited by 21 · see citing works
Dodd, C. N., Andrews, N. J., Petousis‐Harris, H., Sturkenboom, M., Omer, S. B., & BLACK, S. B. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2020-003540 · Cited by 18 · see citing works
Dolhain, J., Janssens, W., Dindore, V., & Mihalyi, A. (2020) · Expert Review of Vaccines · doi:10.1080/14760584.2020.1758560 · Cited by 17 · see citing works
Andrews, N. J., Stowe, J., Thomas, S. L., Walker, J. L., & Miller, E. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.07.059 · Cited by 13 · see citing works
Lessons learned from COVID-19 pandemic: Vaccine platform is a key player
Alhashemi, S. H., Ahmadi, F., & Dehshahri, A. (2022) · Process Biochemistry · doi:10.1016/j.procbio.2022.12.002 · Cited by 10 · see citing works
Pharmacoepidemiologic Studies of Vaccine Safety
Chen, R. T., Glanz, J. M., & Vellozzi, C. J. (2012) · Pharmacoepidemiology · doi:10.1002/9781119959946.ch26 · Cited by 6 · see citing works
Immunisation against COVID-19 in Pregnancy and of Women Planning Pregnancy
Konje, J. C., Beloushi, M. A., & Ahmed, B. (2023) · Viruses · doi:10.3390/v15030621 · Cited by 7 · see citing works
Siegrist, C., & Eberhardt, C. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00002-5 · Cited by 4 · see citing works
Wastila, L. J., Fu, Y., Tung, C. C., & Qato, D. M. (2025) · Drugs - Real World Outcomes · doi:10.1007/s40801-025-00504-y · Cited by 4 · see citing works
Health economic analyses of secondary vaccine effects: a systematic review and policy insights
Thompson, K. M., & Badizadegan, K. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2022.2017287 · Cited by 4 · see citing works
Vaccine efficacy and immune interference: co-administering COVID-19 and influenza vaccines
Altmann, D. M., & Boyton, R. J. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00438-0 · Cited by 3 · see citing works
ADVERSE EVENTS FOLLOWING MEASLES-MUMPS-RUBELLA VACCINATION. A PROSPECTIVE OBSERVATIONAL STUDY
Bucșa, C. (2020) · FARMACIA · doi:10.31925/farmacia.2020.2.5 · Cited by 3 · see citing works
Sørup, S. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.01.011 · Cited by 3 · see citing works
Talking with and advising parents about childhood immunisation
Bedford, H. E. (2013) · Journal of Health Visiting · doi:10.12968/johv.2013.1.1.8 · Cited by 1 · see citing works
Cicchiello, M., Lichtenstern, C. R., & Lamichhane-Khadka, R. (2024) · Preprints.org · doi:10.20944/preprints202403.1665.v1 · Cited by 1 · see citing works
Talking with parents about immunisation
Bedford, H. E. (2017) · Practice Nursing · doi:10.12968/pnur.2017.28.3.104
Dittmann, S. (2011) · Side effects of drugs annual · doi:10.1016/b978-0-444-53741-6.00032-5
Current awareness: Pharmacoepidemiology and drug safety
John Wiley & Sons, L. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1652
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.01614-0
Non-specific Effects of Vaccines
Pittet, L. F., Netea, M. G., & Curtis, N. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00003-7
Petersen, I., Douglas, I., & Whitaker, H. (2016)
Pediatric and Adolescent Immunizations in the Current Era
Linn, A., Ibrahim, O., & Sharma, T. S. (2026) · Current Pediatrics Reports · doi:10.1007/s40124-026-00384-y
- Authors
- Stowe, J., Andrews, N., Taylor, B., & Miller, E.
- Affiliations
- Health Protection Agency (GB)
- University College London (GB)
- Corresponding author
- Stowe, Julia
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 27
- Issue
- 9
- Pages
- 1422-1425
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W2064668271
- Cited by
- 43
- References
- 19
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 5 · 2020: 5 · 2019: 1 · 2017: 3 · 2016: 3 · 2015: 2 · 2014: 3 · 2013: 3 · 2012: 3
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Vaccine (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research (039/031)
- Topics
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- MMR vaccine, post-vaccination infection, invasive bacterial infection, viral infection, herpesvirus infection, multi-antigen vaccine, vaccine safety, self-controlled case series
- MeSH terms
- Admitting Department, Hospital, Adolescent, Child, United Kingdom, Humans, Measles, Measles Vaccine, Mumps, Mumps Vaccine, Rubella, Rubella Vaccine, Seasons, Incidence, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review